1 – 10 of 169
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
(
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer
(
- Contribution to journal › Article
- 2024
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
(
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
2024) European Association for Cancer Research(
- Contribution to conference › Poster
-
Mark
Current and emerging sequencing-based tools for precision cancer medicine
(
- Contribution to journal › Scientific review
-
Mark
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC) : a pooled analysis of seven studies
(
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(
- Contribution to journal › Article
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article